CDH2 and breast cancer: Partial NKILA silencing showed no major effect on EMT markers in either breast cancer cell line, however, miR‐103 delivery in HMECs dramatically attenuated the expression of Vimentin and E‐cadherin, while increasing N‐cadherin expression levels.